Australia - engelsk - Department of Health (Therapeutic Goods Administration)

chiesi australia pty ltd - cannabidiol, quantity: 100 mg/ml - oral liquid, solution - excipient ingredients: sesame oil; sucralose; ethanol absolute; flavour - epidyolex is indicated for use as adjunctive therapy of seizures associated with lennox-gastaut syndrome (lgs) or dravet syndrome (ds) for patients 2 years of age and older.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

chiesi australia pty ltd - beclometasone dipropionate, quantity: 200 microgram; formoterol fumarate dihydrate, quantity: 6 microgram - inhalation, pressurised - excipient ingredients: norflurane; ethanol absolute; hydrochloric acid - asthma fostair is indicated in adults (18 years and older) in the treatment of asthma where use of a combination product (inhaled corticosteroid and long-acting beta2-agonist) is appropriate: - patients not adequately controlled with inhaled corticosteroids (ics) and 'as needed' inhaled rapid-acting beta2-agonist or - patients already adequately controlled on both ics and long-acting beta2-agonists (laba). (see section 4.2 dose and method of administration for treatment approaches).

Storbritannia - engelsk - myHealthbox

chiesi gmbh - dipropionate anhydrous, formoterol fumarate dihydrate. - inhalation powder. - 200 micrograms/6 micrograms for metered dose - rugs for obstructive airway diseases; adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics. - fostair nexthaler is indicated in the regular treatment of asthma where use of a combination product (inhaled corticosteroid and long-acting beta2-agonist) is appropriate: - patients not adequately controlled with inhaled corticosteroids and 'as needed' inhaled short-acting beta2-agonist or - patients already adequately controlled on both inhaled corticosteroids and long-acting beta2-agonists. fostair nexthaler is indicated in adults. note: there are no relevant clinical data on the use of fostair nexthaler for the treatment of acute asthma attacks.

Irland - engelsk - HPRA (Health Products Regulatory Authority)

chiesi limited - piroxicam betadex - tablets effervescent - 20mg milligram

Irland - engelsk - HPRA (Health Products Regulatory Authority)

chiesi limited - piroxicam betadex - tablets - 20mg milligram

Irland - engelsk - HPRA (Health Products Regulatory Authority)

chiesi limited - piroxicam betadex - tablets effervescent - 20mg milligram

Irland - engelsk - HPRA (Health Products Regulatory Authority)

chiesi limited - piroxicam betadex - tablets - 20mg milligram

Storbritannia - engelsk - MHRA (Medicines & Healthcare Products Regulatory Agency)

chiesi ltd - caffeine citrate - solution for infusion - 20mg/1ml

Storbritannia - engelsk - MHRA (Medicines & Healthcare Products Regulatory Agency)

chiesi ltd - levofloxacin hemihydrate - nebuliser liquid - 100mg/1ml

Storbritannia - engelsk - MHRA (Medicines & Healthcare Products Regulatory Agency)

chiesi ltd - beclometasone dipropionate; glycopyrronium bromide; formoterol fumarate dihydrate - pressurised inhalation - 87microgram/1dose ; 9microgram/1dose ; 5microgram/1dose